1. AgeX Therapeutics Appoints John F. Mauldin to Board of Directors

    AgeX Therapeutics Appoints John F. Mauldin to Board of Directors

    ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX) focused on prolonging ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. John is widely recognized for his rare gift of clearly visualizing future trends.
  3. Topics Mentioned